Ohri Manu insider trades
Ohri Manu has filed 7 Form 4s with the SEC that we hold, for GT Biopharma, Inc. (GTBP) (CFO & Secretary) and Axil Brands, Inc. (AXIL) (Director). Across all of them we count 1 purchase worth $25.0K and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 50,000 shares of GT Biopharma, Inc. worth $25.0K, dated 2023-04-06. The first filing on our record is dated 2022-07-19 and the latest 2026-03-04.
GT Biopharma, Inc. (GTBP)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2023-04-06 | P, purchase reported on Form 4 | 50,000 | $25.0K | 2023-04-10 | SEC |
Axil Brands, Inc. (AXIL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1424683) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
